Biotechnology

Filter

Current filters:

None

Popular Filters

1 to 25 of 2402 results

Reasons for Epidermal Growth Factor Receptor failure in liver cancer found by Austrian doctoral program

Reasons for Epidermal Growth Factor Receptor failure in liver cancer found by Austrian doctoral program

24-11-2014

Researchers from the Medical University of Vienna, Austria, have clarified why using therapeutic agents…

AustriaBiotechnologyMedicineOncologyResearch

Positive Ph III results for Relypsa’s patiromer FOS for hyperkalemia

22-11-2014

US biotech firm Relypsa announced that positive results from the pivotal Phase III program of the company's…

BiotechnologyNephrology and HepatologypatiromerRelypsaRenagelRenvelaResearchSanofiZS PharmaZS-9

AstraZeneca to invest $200 million in expanding US biologics manufacturing center

22-11-2014

Anglo-Swedish pharma major AstraZeneca on Friday unveiled plants to expand its biologics manufacturing…

AstraZenecaBiotechnologyFinancialMedImmuneProductionUSA

Stada Arz and mAbxience to negotiate over adalimumab biosimilar

21-11-2014

German drugmaker Stada Arzneimittel and the biotech specialist mAbxience have agreed to negotiate over…

AbbVieadalimumabAnti-Arthritics/RheumaticsBiosimilarsBiotechnologyHumiraLicensingMabxienceSTADA Arzneimittel

Novartis’ Cosentyx wins positive opinion from EMA’s CHMP

Novartis’ Cosentyx wins positive opinion from EMA’s CHMP

21-11-2014

Swiss pharma giant Novartis this morning revealed that the European Medicines Agency’s Committee for…

BiotechnologyCosentyxDermatologicalsEuropeNovartisRegulationsecukinumab

UK government looks to speed up access to new medicines

UK government looks to speed up access to new medicines

20-11-2014

The UK government has announced a substantial investment package from industry, and that it is to carry…

BiotechnologyPoliticsRegulationUKUnited Kingdom

3SBio gains exclusive license for PharmAbcine’s tanibirumab

20-11-2014

Chinese biotech firm 3SBio Inc has entered into an exclusive license with PharmAbcine for the development,…

3SBioBiotechnologyBrazilChinaLicensingOncologyPharmAbcineRussiatanibirumabThailand

Clovis Oncology's rucaparib achieves positive Phase II results

Clovis Oncology's rucaparib achieves positive Phase II results

20-11-2014

Personalized cancer therapy specialist Clovis Oncology has achieved positive results in a Phase II trial…

BiotechnologyClovis OncologyOncologyResearchrucaparibUSA

Sanofi and Regeneron’s dupilumab gets Breakthrough designation from FDA

20-11-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to French pharma major…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Royalty Pharma pays $3.3 billion for CFF royalty rights to Kalydeco

19-11-2014

Royalty Pharma says it has acquired royalties on Vertex Pharmaceuticals' cystic fibrosis treatments,…

BiotechnologyFinancialKalydecoRare diseasesRoyalty PharmaVertex Pharmaceuticals

Sanofi and Regeneron's alirocumab achieves positive Phase III results in reducing LDL

Sanofi and Regeneron's alirocumab achieves positive Phase III results in reducing LDL

19-11-2014

French drug major Sanofi and partner Regeneron Pharmaceuticals have reported results of six Phase III…

alirocumabBiotechnologyGastro-intestinalsRegeneron PharmaceuticalsResearchSanofi

Kynamro achieves significant reduction in MACE

19-11-2014

A retrospective analysis has shown that patients treated with Kynamro (mipomersen sodium) injection for…

BiotechnologyCardio-vascularGenzymeIsis PharmaceuticalsKynamroResearchSanofi

Gilead Sciences’ Harvoni gains EU approval

Gilead Sciences’ Harvoni gains EU approval

19-11-2014

The European Commission yesterday granted marketing authorization for US biotech antiviral specialists…

Anti-viralsBiotechnologyEuropeGilead SciencesHarvoniRegulationSovaldi

Forward Pharma sues Biogen Idec over Tecfidera sales in Germany

18-11-2014

Danish biopharmaceutical company Forward Pharma has filed a law suit against US biotech major Biogen…

Biogen IdecBiotechnologyForward PharmaGermanyLegalMarkets & MarketingNeurologicalTecfidera

Bayer/Regeneron’s Eylea approved in Japan for DME

18-11-2014

German pharma major Bayer’s Japanese subsidiary, Bayer Yakuhin, has received approval from the Ministry…

BayerBiotechnologyEyleaJapanOphthalmicsRegeneronRegulation

Scripps Research Institute scientists reveal weak spots in Ebola's defenses

18-11-2014

Scientists at The Scripps Research Institute (TSRI) have identified weak spots on the surface of Ebola…

Anti-viralsBiotechnologyMapp BiopharmaceuticalResearchTropical diseasesZMapp

Dicerna licenses rights to Tekmira technology

Dicerna licenses rights to Tekmira technology

18-11-2014

US RNAi therapeutics specialist Dicerna Pharmaceuticals has entered a licensing agreement for to use…

BiotechnologyDCR-PH1Dicerna PharmaceuticalsLicensingRare diseasesTekmira PharmaceuticalsUSA

Merck enters lucrative cancer alliance with Pfizer

Merck enters lucrative cancer alliance with Pfizer

17-11-2014

Germany’s Merck KGaA said today that it has entered into a global agreement with US pharma giant Pfizer…

BiotechnologyGermanyLicensingMarkets & MarketingMerck KGaAMerck SeronoMSB0010718COncologyPfizerUSAXalkori

Valeant buys NicOx’ US ophthalmic diagnostics unit

17-11-2014

Ophthalmology-focused French biotech firm NicOx says that Canada’s Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsNicOxOphthalmicsUSAValeant Pharmaceuticals InternationalVesneo

Yet another indication for Roche’s blockbuster Avastin from FDA

16-11-2014

The US Food and Drug Administration on Friday approved Avastin (bevacizumab) solution for intravenous…

AvastinBiotechnologyEli LillyGemzarGenentechOncologyRegulationRocheUSA

FDA at last approves Genzyme’s Lemtrada

FDA at last approves Genzyme’s Lemtrada

15-11-2014

The US Food and Drug Administration on Friday approved French pharma major Sanofi subsidiary Genzyme’s…

BayerBiotechnologyGenzymeLemtradaNeurologicalRegulationSanofiUSA

Bristol-Myers plans biologics manufacturing facility in Ireland

14-11-2014

US pharma major Bristol-Myers Squibb plans to construct a new state-of-the-art, large-scale biologics…

BiotechnologyBristol-Myers SquibbIrelandProduction

Onxeo receives $25M milestone payment from Spectrum on Beleodaq

14-11-2014

Onxeo, created by a merger between French company BioAlliance Pharma, and Danish biopharmaceutical company…

BeleodaqBiotechnologyFinancialHematologyLicensingOncologyOnxeoSpectrum PharmaceuticalsUSA

Geron in up to $935 million deal with Janssen for imetelstat

Geron in up to $935 million deal with Janssen for imetelstat

14-11-2014

Geron Corp has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech,…

BiotechnologyGeron CorpGlobalHematologyimetelstatJanssen BiotechJohnson & JohnsonLicensingOncology

1 to 25 of 2402 results

Back to top